2025年全球醫療健康篩檢市場報告

預計未來幾年，醫療健康篩檢市場將強勁成長，到2029年將達到253.6億美元，複合年成長率為6.5%。預測期內的成長可歸因於個人化醫療的擴展、數位健康平台投資的增加、非傳染性疾病（NCD）盛行率的上升、新興市場中階的壯大以及健康意識的增強。預計這段時期的主要趨勢包括人工智慧在診斷解讀中的應用、穿戴式健康監測設備、整合遠距遠端保健的篩檢工具、可攜式和手持式篩檢設備、人工智慧在篩檢通訊協定中的整合，以及用於健康數據安全的區塊鏈技術。

預計未來幾年，慢性病盛行率的上升將推動醫療健康篩檢市場的成長。慢性病是指長期健康狀況，例如糖尿病、心臟病和氣喘，通常持續一年以上，需要持續的醫療照護或限制日常活動。此類慢性病的增加很大程度上是由於久坐不動的生活方式造成的，長期缺乏身體活動會削弱整體健康狀況，並增加長期疾病的可能性。醫療健康篩檢在慢性病管理中發揮關鍵作用，它能夠及早發現風險因素和症狀，從而及時干預和管理。這可以預防併發症，改善生活品質，並減少這些疾病的整體影響。例如，總部位於比利時的非營利組織國際糖尿病聯合會在2025年4月報告稱，目前全球有5.89億20至79歲的成年人患有糖尿病，並預測到2050年這一數字將增至8.53億。因此，日益加重的慢性病負擔正在刺激醫療健康篩檢市場的擴張。

醫療健康篩檢市場的主要企業正專注於實施尖端解決方案，例如基於人工智慧 (AI) 的放射資訊學和癌症篩檢技術，以提高早期發現、診斷準確性和臨床工作流程效率。基於人工智慧的放射資訊學和癌症篩檢利用人工智慧分析醫學影像數據，以更快、更準確地檢測癌症和其他異常的徵兆。例如，2025 年 2 月，美國醫學資訊學公司 DeepHealth 透過其雲端原生平台 DeepHealth OS 推出了一系列基於人工智慧的放射資訊學和癌症篩檢工具。該套件包括診斷套件、基於人工智慧的綜合診斷工作區以及用於肺、前列腺和腦健康篩檢的高級人工智慧應用。這些創新旨在提高診斷準確性、簡化臨床流程並提高各種醫療環境中的營運效率。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球醫療健康篩檢：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素和限制因素）
• 最終用途產業分析
• 全球醫療健康篩檢市場：成長率分析
• 全球醫療健康篩檢市場表現：規模與成長，2019-2024
• 全球醫療健康篩檢市場預測：規模與成長，2024-2029年，2034年
• 全球醫療健康篩檢：總目標市場（TAM）

第6章 市場細分

• 全球醫療健康篩檢市場（按測試類型）：實際值和預測值（2019-2024 年、2024-2029 年、2034 年）
• 定期檢查
• 不定期檢查
• 癌症篩檢
• 專業檢查
• 其他測試類型
• 全球醫療健康篩檢市場（按樣本類型）：實際值和預測值，2019-2024 年、2024-2029 年、2034 年
• 血
• 尿
• 唾液
• 其他樣本類型
• 全球醫療健康篩檢市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 醫院或診所診斷實驗室
• 職場
• 研究所
• 其他最終用戶
• 全球醫療健康篩檢市場：按常規檢查、類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
• 血壓監測
• 血糖值檢測
• 血脂狀況
• 全血球計數（CBC）
• 尿液檢查
• 全球醫療健康篩檢市場：依非例行檢測細分、類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 基因檢測
• 荷爾蒙測試
• 過敏測試
• 傳染病檢查
• 全球醫療健康篩檢市場：依癌症檢測細分、類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 乳房X光攝影
• 子宮頸抹片抹片檢查
• 大腸鏡檢查
• 前列腺特異性抗原（PSA）檢測
• 肺癌低劑量電腦斷層掃描
• 全球醫療健康篩檢市場：按專業測試、類型、績效和預測細分，2019-2024 年、2024-2029 年、2034 年
• 心血管篩檢
• 神經學篩檢
• 肺功能檢查
• 骨骼密度測試
• 全球醫療健康篩檢市場：按其他測試、類型、實際和預測細分，2019-2024 年、2024-2029 年、2034 年
• 醫療健康篩檢
• 高階主管醫療健康篩檢
• 產前篩檢
• 職業醫療健康篩檢

第7章 區域和國家分析

• 全球醫療健康篩檢市場：按地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球醫療健康篩檢市場：按國家、實際結果和預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 醫療健康篩檢市場：競爭格局
• 醫療健康篩檢市場：公司簡介
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• QuidelOrtho Corporation
• Teladoc Health Inc.
• Exact Sciences Corporation
• Unilabs AB
• LifeLabs LP
• ARUP Laboratories
• BioReference Health LLC
• Guardant Health Inc.
• DDRC Agilus Diagnostics Limited
• Clinical Reference Laboratory Inc.
• Freenome Holdings Inc.
• Genova Diagnostics Inc.
• Cerba Healthcare SAS
• DELFI Diagnostics Inc.
• Truvian Sciences Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

• 2029 年醫療健康篩檢市場：提供新機會的國家
• 2029 年醫療健康篩檢市場：細分領域帶來新機會
• 2029年醫療健康篩檢市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章 附錄

Medical health screening is the systematic process of performing various tests and examinations on seemingly healthy individuals to detect potential health issues or risk factors before symptoms develop. This early detection strategy allows healthcare providers to take timely action, lessen disease severity, and enhance overall health outcomes through preventive care.

The primary categories of tests in medical health screening include routine tests, non-routine tests, cancer screening tests, specialty tests, and others. Routine tests are standard medical examinations conducted regularly to monitor general health and identify potential problems early. These tests involve different sample types, such as blood, urine, saliva, and others, and serve a wide range of end users, including hospitals and clinics, diagnostic laboratories, workplaces, research institutions, and more.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The medical health screening market research report is one of a series of new reports from The Business Research Company that provides medical health screening market statistics, including medical health screening industry global market size, regional shares, competitors with a medical health screening market share, detailed medical health screening market segments, market trends and opportunities, and any further data you may need to thrive in the medical health screening industry. This medical health screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical health screening market size has grown strongly in recent years. It will grow from $18.50 billion in 2024 to $19.74 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth during the historic period can be attributed to the rising incidence of chronic diseases, government-driven preventive health campaigns, an aging global population, expanded insurance coverage, and a higher frequency of routine check-ups.

The medical health screening market size is expected to see strong growth in the next few years. It will grow to $25.36 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to the expansion of personalized medicine, increased investment in digital health platforms, the rising prevalence of non-communicable diseases (NCDs), the growing middle class in emerging markets, and heightened health consciousness. Key trends expected during this period include the use of artificial intelligence in diagnostic interpretation, wearable health monitoring devices, telehealth-integrated screening tools, portable and handheld screening devices, AI integration in screening protocols, and blockchain technology for health data security.

The rising prevalence of chronic diseases is expected to drive the growth of the medical health screening market in the coming years. Chronic diseases are long-term health conditions-such as diabetes, heart disease, and asthma-that typically last a year or more and require ongoing medical care or limit daily activities. This increase in chronic diseases is largely due to sedentary lifestyles, where extended inactivity weakens overall health and raises susceptibility to long-term conditions. Medical health screening plays a crucial role in managing chronic diseases by enabling early detection of risk factors and symptoms, which allows for timely intervention and management. This can help prevent complications, improve quality of life, and lessen the overall impact of these diseases. For example, in April 2025, the International Diabetes Federation, a Belgium-based non-profit organization, reported that 589 million adults aged 20-79 are currently living with diabetes worldwide, a number projected to rise to 853 million by 2050. Thus, the growing burden of chronic diseases is fueling the expansion of the medical health screening market.

Key players in the medical health screening market are focusing on introducing cutting-edge solutions such as artificial intelligence (AI)-powered radiology informatics and cancer screening technologies to improve early detection, diagnostic accuracy, and clinical workflow efficiency. AI-powered radiology informatics and cancer screening involve using AI to analyze medical imaging data and detect signs of cancer or other abnormalities more quickly and accurately. For instance, in February 2025, DeepHealth, a US-based health informatics company, launched a new range of AI-driven radiology informatics and cancer screening tools through their cloud-native platform, DeepHealth OS. This suite includes the Diagnostic Suite, a comprehensive AI-based diagnostic workspace, along with advanced AI applications for screening lung, prostate, and brain health. These innovations are designed to boost diagnostic precision, streamline clinical processes, and enhance operational efficiency across various healthcare environments.

In January 2023, PAM Group, a UK-based provider of occupational health, rehabilitation, and absence management services, acquired MedProtect for an undisclosed sum. This acquisition is aimed at strengthening PAM Group's position in the occupational health and wellbeing sector by integrating MedProtect's specialized mobile health screening services. The combined entity is now able to offer more cost-effective health solutions to a wider client base while promoting continued growth and innovation within the industry. MedProtect, based in the UK, offers occupational health screening services, including mobile units for hearing tests, biological monitoring, and lung function evaluations.

Major players in the medical health screening market are Abbott Laboratories, Siemens Healthineers AG, Labcorp Holdings Inc., Quest Diagnostics Incorporated, Eurofins Scientific SE, QuidelOrtho Corporation, Teladoc Health Inc., Exact Sciences Corporation, Unilabs AB, LifeLabs LP, ARUP Laboratories, BioReference Health LLC, Guardant Health Inc., DDRC Agilus Diagnostics Limited, Clinical Reference Laboratory Inc., Freenome Holdings Inc., Genova Diagnostics Inc., Cerba Healthcare SAS, DELFI Diagnostics Inc., Truvian Sciences Inc., ACM Medical Laboratory Inc., LabPlus, and BlueHive Health.

North America was the largest region in the medical health screening market in 2024. The regions covered in medical health screening report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the medical health screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical health screening market includes revenues earned by entities by providing services such as blood pressure measurement, mental health assessment, infectious disease screening, immunization status review, and lifestyle risk assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Health Screening Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical health screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical health screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical health screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Routine Tests; Non-Routine Tests; Cancer Screening Tests; Specialty Tests; Other Test Types
• 2) By Sample Type: Blood; Urine; Saliva; Other Sample Types
• 3) By End User: Hospitals Or Clinics Diagnostic Laboratories; Workplaces; Research Institutes; Other End Users
• Subsegments:
• 1) By Routine Tests: Blood Pressure Monitoring; Blood Glucose Testing; Lipid Profile; Complete Blood Count (CBC); Urinalysis
• 2) By Non-Routine Tests: Genetic Testing; Hormonal Testing; Allergy Testing; Infectious Disease Testing
• 3) By Cancer Screening Tests: Mammography; Pap Smear Test; Colonoscopy; Prostate-Specific Antigen (PSA) Test; Low-Dose CT Scan For Lung Cancer
• 4) By Specialty Tests: Cardiovascular Screening; Neurological Screening; Pulmonary Function Tests; Bone Density Test
• 5) By Other Test Types: Wellness Tests; Executive Health Checkups; Prenatal Screening; Occupational Health Screening
• Companies Mentioned: Abbott Laboratories; Siemens Healthineers AG; Labcorp Holdings Inc.; Quest Diagnostics Incorporated; Eurofins Scientific SE; QuidelOrtho Corporation; Teladoc Health Inc.; Exact Sciences Corporation; Unilabs AB; LifeLabs LP; ARUP Laboratories; BioReference Health LLC; Guardant Health Inc.; DDRC Agilus Diagnostics Limited; Clinical Reference Laboratory Inc.; Freenome Holdings Inc.; Genova Diagnostics Inc.; Cerba Healthcare SAS; DELFI Diagnostics Inc.; Truvian Sciences Inc.; ACM Medical Laboratory Inc.; LabPlus; BlueHive Health.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Health Screening Market Characteristics

3. Medical Health Screening Market Trends And Strategies

4. Medical Health Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Medical Health Screening Growth Analysis And Strategic Analysis Framework

• 5.1. Global Medical Health Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Medical Health Screening Market Growth Rate Analysis
• 5.4. Global Medical Health Screening Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Medical Health Screening Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Medical Health Screening Total Addressable Market (TAM)

6. Medical Health Screening Market Segmentation

• 6.1. Global Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Routine Tests
• Non-Routine Tests
• Cancer Screening Tests
• Specialty Tests
• Other Test Types
• 6.2. Global Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood
• Urine
• Saliva
• Other Sample Types
• 6.3. Global Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals Or Clinics Diagnostic Laboratories
• Workplaces
• Research Institutes
• Other End Users
• 6.4. Global Medical Health Screening Market, Sub-Segmentation Of Routine Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Blood Pressure Monitoring
• Blood Glucose Testing
• Lipid Profile
• Complete Blood Count (CBC)
• Urinalysis
• 6.5. Global Medical Health Screening Market, Sub-Segmentation Of Non-Routine Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genetic Testing
• Hormonal Testing
• Allergy Testing
• Infectious Disease Testing
• 6.6. Global Medical Health Screening Market, Sub-Segmentation Of Cancer Screening Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mammography
• Pap Smear Test
• Colonoscopy
• Prostate-Specific Antigen (PSA) Test
• Low-Dose CT Scan For Lung Cancer
• 6.7. Global Medical Health Screening Market, Sub-Segmentation Of Specialty Tests, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Screening
• Neurological Screening
• Pulmonary Function Tests
• Bone Density Test
• 6.8. Global Medical Health Screening Market, Sub-Segmentation Of Other Test Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wellness Tests
• Executive Health Checkups
• Prenatal Screening
• Occupational Health Screening

7. Medical Health Screening Market Regional And Country Analysis

• 7.1. Global Medical Health Screening Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Medical Health Screening Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Health Screening Market

• 8.1. Asia-Pacific Medical Health Screening Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Health Screening Market

• 9.1. China Medical Health Screening Market Overview
• 9.2. China Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Health Screening Market

• 10.1. India Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Health Screening Market

• 11.1. Japan Medical Health Screening Market Overview
• 11.2. Japan Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Health Screening Market

• 12.1. Australia Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Health Screening Market

• 13.1. Indonesia Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Health Screening Market

• 14.1. South Korea Medical Health Screening Market Overview
• 14.2. South Korea Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Health Screening Market

• 15.1. Western Europe Medical Health Screening Market Overview
• 15.2. Western Europe Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Health Screening Market

• 16.1. UK Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Health Screening Market

• 17.1. Germany Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Health Screening Market

• 18.1. France Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Health Screening Market

• 19.1. Italy Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Health Screening Market

• 20.1. Spain Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Health Screening Market

• 21.1. Eastern Europe Medical Health Screening Market Overview
• 21.2. Eastern Europe Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Health Screening Market

• 22.1. Russia Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Health Screening Market

• 23.1. North America Medical Health Screening Market Overview
• 23.2. North America Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Health Screening Market

• 24.1. USA Medical Health Screening Market Overview
• 24.2. USA Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Health Screening Market

• 25.1. Canada Medical Health Screening Market Overview
• 25.2. Canada Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Health Screening Market

• 26.1. South America Medical Health Screening Market Overview
• 26.2. South America Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Health Screening Market

• 27.1. Brazil Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Health Screening Market

• 28.1. Middle East Medical Health Screening Market Overview
• 28.2. Middle East Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Health Screening Market

• 29.1. Africa Medical Health Screening Market Overview
• 29.2. Africa Medical Health Screening Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Medical Health Screening Market, Segmentation By Sample Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Medical Health Screening Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Health Screening Market Competitive Landscape And Company Profiles

• 30.1. Medical Health Screening Market Competitive Landscape
• 30.2. Medical Health Screening Market Company Profiles
  • 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Labcorp Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis

31. Medical Health Screening Market Other Major And Innovative Companies

• 31.1. QuidelOrtho Corporation
• 31.2. Teladoc Health Inc.
• 31.3. Exact Sciences Corporation
• 31.4. Unilabs AB
• 31.5. LifeLabs LP
• 31.6. ARUP Laboratories
• 31.7. BioReference Health LLC
• 31.8. Guardant Health Inc.
• 31.9. DDRC Agilus Diagnostics Limited
• 31.10. Clinical Reference Laboratory Inc.
• 31.11. Freenome Holdings Inc.
• 31.12. Genova Diagnostics Inc.
• 31.13. Cerba Healthcare SAS
• 31.14. DELFI Diagnostics Inc.
• 31.15. Truvian Sciences Inc.

32. Global Medical Health Screening Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Health Screening Market

34. Recent Developments In The Medical Health Screening Market

35. Medical Health Screening Market High Potential Countries, Segments and Strategies

• 35.1 Medical Health Screening Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Medical Health Screening Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Medical Health Screening Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer